- Research works
- 3 fractional, all time
- Citations
- 24 9.3 per fractional work
- Top-10% rate
- 15.4% record average 16.5%
- Open access
- 52% world 28%
Not ranked overall: Univercells (Belgium) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Which research topics does Univercells (Belgium) publish most on?
By volume in 2022–2025: Transgenic Plants and Applications, Viral Infectious Diseases and Gene Expression in Insects, Virus-based gene therapy research and Biomedical and Engineering Education.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Transgenic Plants and Applications Biotechnology 0 works
- 2 Viral Infectious Diseases and Gene Expression in Insects Molecular Biology 0 works
- 3 Virus-based gene therapy research Genetics 0 works
- 4 Biomedical and Engineering Education Biomedical Engineering 0 works
- 5 Healthcare cost, quality, practices General Health Professions 0 works
- 6 Global Health and Surgery Public Health, Environmental and Occupational Health 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Univercells (Belgium)'s research output changed?
Other research institutions in Charleroi
- Grand Charleroi Hospital
- Hôpital Civil de Charleroi
- Institute of Pathology and Genetics
- Centre d'Excellence en Technologies de l'Information et de la Communication
- Cenaero (Belgium)
- Bone Therapeutics
- Euroscreen (Belgium)
- Sonaca (Belgium)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.